Core Viewpoint - Reflex Advanced Materials Corp. has entered into debt settlement agreements totaling $420,000 through the issuance of 2,800,000 units at a price of $0.15 per unit, which includes common shares and warrants [2][3]. Debt Settlement Agreements - The company will settle debts amounting to $420,000 by issuing 2,800,000 units, each consisting of one common share and one share purchase warrant [2]. - Each warrant can be converted into one share at a price of $0.20 for a period of two years [2]. Related Party Transaction - One of the agreements is classified as a "related party transaction" as it involves a company owned by an officer of Reflex [3]. - The company is relying on exemptions from certain requirements under Multilateral Instrument 61-101, as the fair market value of the transaction does not exceed 25% of the company's market capitalization [3]. Regulatory Approval - The agreements and the issuance of securities are subject to approval from the Canadian Securities Exchange (CSE) [4]. - The securities will be subject to a hold period of four months and one day in accordance with applicable securities laws [4]. Company Overview - Reflex Advanced Materials Corp. is a mineral exploration company based in British Columbia, focused on developing economic mineral properties in strategic metals and advanced materials [5]. - The company aims to enhance domestic specialty mineral infrastructure to meet the increasing demand from North American manufacturers [5].

Core Viewpoint - Elixxer Ltd. has successfully settled a total of $6,923,742.46 through the issuance of 83,924,151 common shares at a deemed price of $0.0825 per share as part of a debt settlement process [1] Group 1: Debt Settlement Details - The debt settlement was approved by disinterested shareholders during the annual and special shareholder meeting held on December 30, 2025 [2] - This transaction is classified as a "related party transaction" under Multilateral Instrument 61-101, with certain insiders receiving 79,075,667 common shares [3] - The board of directors, excluding two members, approved the debt settlement without establishing a special committee or expressing any contrary views [4] Group 2: Shareholder Impact - Prior to the debt settlement, AIP Convertible Private Debt Fund L.P. held 3,633,391 common shares, representing approximately 32.04% of the total shares on an undiluted basis [5] - After the settlement, AIP's holdings increased to 80,284,815 common shares, equating to approximately 84.28% of the issued shares on an undiluted basis [5] Group 3: Company Overview - Elixxer Ltd. is a Canadian public company listed on the TSX Venture Exchange and the US OTC-Pink exchange, focusing on investments in Canada and other countries while seeking new high-growth opportunities [6]

Core Viewpoint - Reflex Advanced Materials Corp. has entered into a debt settlement agreement to settle a debt of $45,000 through the issuance of 246,981 common shares at a deemed price of $0.1822 per share [1]. Group 1: Debt Settlement Agreement - The debt settlement agreement involves a total debt of $45,000 [1]. - The company will issue 246,981 common shares at a price of $0.1822 per share to settle this debt [1]. - The agreement and issuance of securities are subject to approval from the Canadian Securities Exchange (CSE) [2]. Group 2: Company Overview - Reflex Advanced Materials Corp. is a mineral exploration company based in British Columbia [3]. - The company's objective is to locate and develop economic mineral properties in the strategic metals and advanced materials sector [3]. - Reflex aims to improve domestic specialty mineral infrastructure efficiencies to meet the increasing demand from North American manufacturers [3].

Core Viewpoint - Cybeats Technologies Corp. and Scryb Inc. have successfully completed a debt settlement transaction, enhancing Cybeats' financial position and supporting its operational and growth initiatives [4]. Debt Settlement Details - Cybeats settled $1,200,000 owed under a secured debenture held by Scryb by issuing 10,000,000 common shares at a deemed price of $0.12 per share [2]. - The common shares issued are subject to a statutory hold period of four months and one day [2]. - The completion of the debt settlement did not create any new control person of Cybeats [2]. Related Party Transaction - As Scryb is a control person of Cybeats, the debt settlement is classified as a "related party transaction" under Multilateral Instrument 61-101 [3]. - The companies relied on exemptions from formal valuation and minority shareholder approval requirements, as the fair market value of the debt settlement did not exceed 25% of their respective market capitalizations [3]. Company Profiles - Cybeats Technologies Corp. specializes in cybersecurity, providing Software Bill of Material management and software supply chain intelligence technology [6]. - Scryb Inc. invests in and supports a portfolio of innovative ventures across the technology sector [7].

Core Viewpoint - Bitcoin Well Inc. announces a shares-for-debt settlement, the grant of stock options, and related early warning disclosure, aiming to enhance its financial position and support its mission to enable independence through bitcoin [1]. Debt Settlement - The company will settle C$291,095 of accrued interest obligations by issuing common shares [2]. - As of January 2, 2026, the company has a total debt of C$210,495 related to certain use of bitcoin agreements and a convertible debenture agreement, with C$96,683 settled by issuing 920,788 shares at C$0.105 per share and C$113,813 settled by issuing 1,354,916 shares at C$0.084 per share [3]. - The company also has C$80,600 in convertible debenture interest debt, which will be settled by issuing 739,449 shares at C$0.109 per share [4]. - Additionally, the company has C$62,905.50 in sponsorship agreement debt, settled by issuing 698,950 shares at C$0.09 per share [5]. - The overall debt settlement is subject to approval from the TSX Venture Exchange [6]. Private Placement - The company has closed its private placement offering, raising approximately C$12,492,081.22 from the sale of 122,471,380 units, including C$6,618,460 in cash and 37.31 Bitcoin valued at approximately C$5,873,621.11 [8][9]. Grant of Stock Options - The company granted stock options to purchase up to 8,292,500 shares at an exercise price of C$0.105 per share, with a vesting schedule over three years and a term of five years [10]. Related Party Transactions - Participation by certain directors and officers in the debt settlement and option grant constitutes related party transactions, with the company relying on exemptions from formal valuation and minority shareholder approval requirements [11]. Early Warning Disclosure - Adam O'Brien, the CEO, acquired 1,800,000 options, maintaining approximately 23.88% of the issued shares on a non-diluted basis and increasing to approximately 25.43% on a partially diluted basis following the option grant [12].

Core Viewpoint - Cybeats Technologies Corp. and Scryb Inc. have entered into a debt settlement agreement to settle a secured debenture of $1,200,000 through the issuance of 10,000,000 common shares at a deemed price of $0.12 per share, aimed at improving Cybeats' financial position for future growth [1][2]. Group 1: Debt Settlement Details - The debt settlement agreement is dated December 30, 2025, and involves the issuance of 10,000,000 common shares of Cybeats at a price of $0.12 per share [1]. - The debt settlement is subject to acceptance for filing by the Canadian Securities Exchange, and the issued shares will be subject to a four-month and one-day hold [2]. - The transaction is classified as a "related party transaction" since Scryb is a control person of Cybeats, and the companies will rely on exemptions from certain requirements under Multilateral Instrument 61-101 [3]. Group 2: Company Backgrounds - Cybeats Technologies Corp. specializes in cybersecurity, providing Software Bill of Material (SBOM) management and software supply chain intelligence technology to help organizations manage risk and comply with regulations [5]. - Scryb Inc. invests in and supports a portfolio of innovative ventures in the technology sector [6].

Group 1 - Hampton Financial Corporation has reached agreements to settle obligations under debentures totaling $4 million and a quarterly interest payment of $5.2 million by issuing subordinate voting shares at a deemed price of $0.40 per share [1] - The debt settlement transactions are expected to close on or before December 31, 2025, resulting in the issuance of 10,528,141 subordinate voting shares to debenture holders [1] - This measure aims to strengthen the company's balance sheet and reduce the cash cost of funding operations, with a meaningful impact anticipated on 2026 results [1] Group 2 - Hampton is a private equity firm focused on building shareholder value through long-term strategic investments [2] - The company, through its subsidiary Hampton Securities Limited, is engaged in family office, wealth management, institutional services, and capital markets activities, providing a full range of investment banking services [3] - Hampton Securities Limited is regulated by CIRO and operates in multiple Canadian provinces, assisting companies with capital raising, mergers and acquisitions, and listings on recognized securities exchanges [3] Group 3 - Through its subsidiary Oxygen Working Capital, the company offers factoring and commercial financing services across Canada [4] - Hampton is exploring opportunities to diversify revenue sources through strategic investments in complementary and non-core sectors [4]

Core Viewpoint - Visionary Copper and Gold Mines Inc. has successfully closed the second and final tranche of its non-brokered private placement, raising a total of $3,040,262 through the issuance of charity flow-through units and Manitoba charity flow-through units [1][2]. Group 1: Private Placement Details - The company issued 1,333,334 charity flow-through units at $1.11 per unit, generating gross proceeds of $1,480,000.74, and 267,176 Manitoba charity flow-through units at $1.31 per unit, generating gross proceeds of $350,000.56 [1]. - Each charity flow-through unit consists of one flow-through common share and one-half of a transferable common share purchase warrant, with each warrant exercisable into one additional common share at an exercise price of C$1.10 for two years from closing [2]. - The company has the right to accelerate the expiry date of the warrants if the volume weighted average price of the common shares reaches $1.50 for 10 consecutive trading days [2]. Group 2: Use of Proceeds - The gross proceeds from the sale of flow-through units will be utilized to incur eligible "Canadian exploration expenses" related to the Pt. Leamington Project in Newfoundland, which will qualify as "flow-through critical mineral mining expenditures" [4]. Group 3: Debt Settlement - The company has agreed to settle indebtedness totaling $584,532 with certain creditors by issuing 446,043 common shares, which will also be subject to resale restrictions for four months [6].

Core Viewpoint - Alaska Energy Metals Corporation has issued 6,921,087 common shares at a price of $0.10 per share to settle debts totaling $599,408.70 owed to various creditors [1] Debt Settlements - The total number of Settlement Shares issued is 6,921,087, which were provided to creditors in exchange for services rendered to the company [1] - The total debt settled through this issuance amounts to $599,408.70 [1] - Among the Settlement Shares, 1,118,670 were issued to Non-Arm's Length Parties, settling debts totaling $111,867.00 [1]

Core Viewpoint - Quantum BioPharma Ltd. has successfully closed a non-brokered private placement, issuing 30 Class A Multiple Voting Shares at a price of $25 each, resulting in gross proceeds of $750 million [1][2]. Offering Details - The securities issued are subject to a statutory hold period of four months plus a day from issuance as per Canadian securities laws [2]. - Proceeds from the offering will be utilized for general working capital purposes [2]. Related Party Transactions - Xorax Family Trust and Fortius Research and Trading Corp., both associated with company insiders, purchased all Class A Multiple Voting Shares in the offering, qualifying as a related-party transaction under MI 61-101 [3]. - The company has relied on exemptions from formal valuation and minority shareholder approval requirements as the transaction did not exceed 25% of the company's market capitalization [3]. Corporate Update - The company has terminated its at-the-market offering agreement with H.C. Wainwright & Co., effective December 6, 2025, with the termination taking effect on December 20, 2025 [16]. - No Class B Subordinate Voting Shares have been sold under the previous sales agreement, which allowed for the sale of up to $21.225 million worth of shares [17]. Debt Settlement - Quantum BioPharma has settled $260,000 owed to an arm's length creditor by issuing 17,626 Class B Subordinate Voting Shares at a deemed price of $14.75 per share [18]. Company Overview - Quantum BioPharma focuses on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders, with its lead compound, Lucid-MS, aimed at preventing myelin degradation associated with multiple sclerosis [19]. - The company retains a 20.11% ownership stake in Unbuzzd Wellness Inc., which includes a royalty agreement of 7% on sales until reaching $250 million, after which the royalty will drop to 3% [19].